The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer.
about
Transporting antitumor drug tamoxifen and its metabolites, 4-hydroxytamoxifen and endoxifen by chitosan nanoparticlesSTAT3 mediates resistance of CD44(+)CD24(-/low) breast cancer stem cells to tamoxifen in vitro.Tumor-associated, estrogen receptor-related antigen EBAG9: linking intracellular vesicle trafficking, immune homeostasis, and malignancy.Identification of a hormone-regulated dynamic nuclear actin network associated with estrogen receptor alpha in human breast cancer cell nuclei.p53 nuclear accumulation and ERalpha expression in ductal hyperplasia of breast in a cohort of 215 Chinese women.The emerging role of Krüppel-like factors in endocrine-responsive cancers of female reproductive tissues.Targeting steroid receptor coactivator 1 with antisense oligonucleotides increases insulin-stimulated skeletal muscle glucose uptake in chow-fed and high-fat-fed male ratsWithaferin a suppresses estrogen receptor-α expression in human breast cancer cellsBeta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survivalCoactivators enable glucocorticoid receptor recruitment to fine-tune estrogen receptor transcriptional responses.ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer.PDZK1 is a novel factor in breast cancer that is indirectly regulated by estrogen through IGF-1R and promotes estrogen-mediated growth.Diallyl trisulfide inhibits estrogen receptor-α activity in human breast cancer cells.The role of metabolites and metabolomics in clinically applicable biomarkers of disease.
P2860
Q28488379-7F9AD708-B68D-4606-82B9-7E132FBD901BQ30420135-0A7C3C6C-52CD-4EAC-BDDD-49EAE06178C8Q33655825-297AC666-0DCA-4ABE-9BBD-690C7C225752Q33883078-D33C3CC8-5E0A-4E55-A1C6-10CF0F98AD1AQ34114248-316B7BEE-AD28-4741-8340-B7265135588DQ34271842-EF42A4B6-66E6-4828-8804-30216EA488CCQ34439547-64AAD25A-ACE6-479D-AB0C-92FE758888BDQ35085709-6BCDE2E4-FF93-4C63-A7E0-4930B7EF9031Q35640094-5FEA3C9F-A29F-4C99-9F5F-03C64A2DFD4DQ36769499-95B76AC2-60BB-461D-8CE5-CD8EAAC3384FQ37013898-E260CFDA-628D-4AD0-A7A1-E9C435ADDBC1Q37161525-5760EE43-7F65-44EC-ADBA-4B1A62B7DAD0Q37615049-E6C4D20B-4549-4C37-A718-FF4DA9C449D7Q37800811-D2241D25-416F-49A9-82F1-F110162658BF
P2860
The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The potential role of estrogen ...... he treatment of breast cancer.
@ast
The potential role of estrogen ...... he treatment of breast cancer.
@en
The potential role of estrogen ...... he treatment of breast cancer.
@nl
type
label
The potential role of estrogen ...... he treatment of breast cancer.
@ast
The potential role of estrogen ...... he treatment of breast cancer.
@en
The potential role of estrogen ...... he treatment of breast cancer.
@nl
prefLabel
The potential role of estrogen ...... he treatment of breast cancer.
@ast
The potential role of estrogen ...... he treatment of breast cancer.
@en
The potential role of estrogen ...... he treatment of breast cancer.
@nl
P2860
P1476
The potential role of estrogen ...... he treatment of breast cancer.
@en
P2093
John Bartlett
Melanie Spears
P2860
P304
P356
10.1517/14728220902911509
P407
P577
2009-06-01T00:00:00Z